Gene: UBE2H
Official Full Name: ubiquitin conjugating enzyme E2 Hprovided by HGNC
Gene Summary: The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein sequence is 100% identical to the mouse homolog and 98% identical to the frog and zebrafish homologs. Three alternatively spliced transcript variants have been found for this gene and they encode distinct isoforms. [provided by RefSeq, Feb 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01849 | UBE2H Knockout cell line (HeLa) | Human | UBE2H | 1:3~1:6 | Negative | Online Inquiry |
KO01850 | UBE2H Knockout cell line (HCT 116) | Human | UBE2H | 1:2~1:4 | Negative | Online Inquiry |
KO01851 | UBE2H Knockout cell line (HEK293) | Human | UBE2H | 1:3~1:6 | Negative | Online Inquiry |
KO01852 | UBE2H Knockout cell line (A549) | Human | UBE2H | 1:3~1:4 | Negative | Online Inquiry |
UBE2H Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to lack the UBE2H gene, which encodes an E2 ubiquitin-conjugating enzyme implicated in a variety of cellular processes, particularly those related to protein turnover and cellular signaling pathways. These cell lines serve as crucial tools for dissecting the intricate roles of ubiquitination in cellular function and disease states, enabling researchers to investigate the downstream effects of UBE2H deficiency on cellular processes such as apoptosis, cell proliferation, and stress responses.
The mechanism by which UBE2H operates is centered around its role in conjugating ubiquitin molecules to target proteins, a post-translational modification that often labels substrates for degradation via the proteasome or alters their cellular localization, activity, or interactions. By creating knockout cell lines, scientists can study the absence of this enzyme's function, providing insights into the regulatory networks governed by ubiquitination, which are often altered in various pathologies including cancer and neurodegenerative diseases.
In a research or clinical context, UBE2H Gene Knockout Cell Lines offer extensive applicability. They facilitate the exploration of disease mechanisms, provide robust platforms for drug discovery and testing, and enable the validation of therapeutic targets associated with the ubiquitin-proteasome system. The ability to manipulate cellular phenotypes based on the absence of specific gene function significantly enhances the opportunities for novel therapeutic interventions.
Compared to alternative cellular models, the unique advantage of UBE2H Gene Knockout Cell Lines lies in their specific focus on the ubiquitin pathway, thereby offering a precise and effective means to understand the implications of UBE2H loss in biological systems. Additionally, their ready availability allows for a streamlined approach in experiments, saving valuable time and resources.
Researchers and clinicians will find value in utilizing UBE2H Gene Knockout Cell Lines due to their potential to elucidate fundamental biological questions and accelerate the translation of laboratory findings into therapeutic applications. With the promise of advancing scientific knowledge and clinical practices, these cell lines stand as indispensable resources in the realm of molecular biology.
As a leading supplier of advanced genetic tools, our company possesses extensive expertise in developing and delivering high-quality biological products, ensuring that researchers have access to the best models necessary for groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.